Pharmacodynamics of a Liver-Targeted Dextran Prodrug of Methylprednisolone

[From Introduction] In summary, this dissertation demonstrates that following systemic administration, dextran prodrug of methylprednisolone has a more intense and sustained immunosuppressive activity in the liver compared to equimolar doses of MP.